Becton Dickinson (BDX) Tops Q1 EPS by 30c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
BD Reports First Quarter Fiscal 2023 Financial Results
February 2, 2023 6:30 AM ESTExecution of BD 2025 Strategy Delivering Consistent and Durable Performance
Revenue of $4.6 billion decreased 2.8% as reported and increased 1.7% on a currency-neutral basisRevenue from base business (which excludes COVID-only diagnostic testing) grew 0.4% as reported, 5.2% currency-neutralGAAP and adjusted diluted EPS from continuing operations of $1.70 and $2.98, respectivelyCompany raises full-year revenue and adjusted EPS guidanceFRANKLIN LAKES, N.J., Feb. 2, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal 2023, which ended December 31, 2022.
... More